Modern antipsychotic drugs: a critical overview.

CMAJ

Department of Psychiatry and College of Pharmacy, Dalhousie University, Halifax, NS.

Published: June 2005

Conventional antipsychotic drugs, used for a half century to treat a range of major psychiatric disorders, are being replaced in clinical practice by modern "atypical" antipsychotics, including aripiprazole, clozapine, olanzapine, quetiapine, risperidone and ziprasidone among others. As a class, the newer drugs have been promoted as being broadly clinically superior, but the evidence for this is problematic. In this brief critical overview, we consider the pharmacology, therapeutic effectiveness, tolerability, adverse effects and costs of individual modern agents versus older antipsychotic drugs. Because of typically minor differences between agents in clinical effectiveness and tolerability, and because of growing concerns about potential adverse long-term health consequences of some modern agents, it is reasonable to consider both older and newer drugs for clinical use, and it is important to inform patients of relative benefits, risks and costs of specific choices.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1150265PMC
http://dx.doi.org/10.1503/cmaj.1041064DOI Listing

Publication Analysis

Top Keywords

antipsychotic drugs
12
critical overview
8
newer drugs
8
effectiveness tolerability
8
modern agents
8
drugs
5
modern
4
modern antipsychotic
4
drugs critical
4
overview conventional
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!